<p>STARHS assay results over time among participants with incident HIV in prospective cohort (N = 11).</p
Tests for recent infections (TRIs) are important for HIV surveillance. We have shown that a patient'...
Tests for recent infections (TRIs) are important for HIV surveillance. We have shown that a patient'...
To assess the performance of BED-CEIA (BED) and AxSYM Avidity Index (Ax-AI) assays in estimating HIV...
Performance of the BED assay in estimating HIV-1 incidence has previously been evaluated by using lo...
Record numbers of new diagnoses of HIV infection have been recorded in the UK in recent years. Howev...
BACKGROUND: Performance of the BED assay in estimating HIV-1 incidence has previously been evaluated...
<p>Correlation of results on BED-CEIA and AxSYM Avidity Index for recent HIV infection, Cross-sectio...
<p>The retested cumulative incidence category is calculated as the number of new infections per numb...
OBJECTIVE:HIV seroconversion biomarkers are being used in cross-sectional studies for HIV incidence ...
This is the official assay evaluation report on Sedia Biosciences Corporation's Asanté™ HIV-1 Rapid ...
Serologic testing algorithms for recent HIV seroconversion (STARHS) provide important information fo...
A study was designed to compare an avidity index method to the serologic testing algorithm for recen...
The epidemiologic utility of STARHS hinges not only on producing accurate estimates of HIV incidence...
Mean time since last HIV test (in years), bivariate and multivariate linear regression, by region of...
<p>Abbreviations: RI = recent infection; LTI = long-term infection.</p>1<p>P-values for the Chi-squa...
Tests for recent infections (TRIs) are important for HIV surveillance. We have shown that a patient'...
Tests for recent infections (TRIs) are important for HIV surveillance. We have shown that a patient'...
To assess the performance of BED-CEIA (BED) and AxSYM Avidity Index (Ax-AI) assays in estimating HIV...
Performance of the BED assay in estimating HIV-1 incidence has previously been evaluated by using lo...
Record numbers of new diagnoses of HIV infection have been recorded in the UK in recent years. Howev...
BACKGROUND: Performance of the BED assay in estimating HIV-1 incidence has previously been evaluated...
<p>Correlation of results on BED-CEIA and AxSYM Avidity Index for recent HIV infection, Cross-sectio...
<p>The retested cumulative incidence category is calculated as the number of new infections per numb...
OBJECTIVE:HIV seroconversion biomarkers are being used in cross-sectional studies for HIV incidence ...
This is the official assay evaluation report on Sedia Biosciences Corporation's Asanté™ HIV-1 Rapid ...
Serologic testing algorithms for recent HIV seroconversion (STARHS) provide important information fo...
A study was designed to compare an avidity index method to the serologic testing algorithm for recen...
The epidemiologic utility of STARHS hinges not only on producing accurate estimates of HIV incidence...
Mean time since last HIV test (in years), bivariate and multivariate linear regression, by region of...
<p>Abbreviations: RI = recent infection; LTI = long-term infection.</p>1<p>P-values for the Chi-squa...
Tests for recent infections (TRIs) are important for HIV surveillance. We have shown that a patient'...
Tests for recent infections (TRIs) are important for HIV surveillance. We have shown that a patient'...
To assess the performance of BED-CEIA (BED) and AxSYM Avidity Index (Ax-AI) assays in estimating HIV...
DOI
Add to ORKG